Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Dr. Prem Aggarwal

Dr Prem Aggarwal, (MD Medicine, DNB Cardiology) is a Cardiologist by profession and also the Co-founder and Chairman of Medical Dialogues. He focuses on news and perspectives about cardiology, and medicine related developments at Medical Dialogues. He can be reached out at drprem@medicaldialogues.in

Home

Dr. Prem Aggarwal

Articles By : Dr. Prem Aggarwal

AI model can read ECGs to identify female patients at higher risk of heart disease: Study

Dr. Prem Aggarwal13 March 2025 9:00 PM IST

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG).The researchers say the algorithm,...

Heart Fibrosis Linked to Mortality in Aortic Stenosis: Does Sex Matter? Study Sheds Light

Dr. Prem Aggarwal12 March 2025 8:15 AM IST

South Korea: A recent study has highlighted the sex-specific implications of myocardial fibrosis on mortality in patients with severe aortic stenosis...

Breakthrough cardiac regeneration research offers hope for the treatment of ischemic heart failure

Dr. Prem Aggarwal11 March 2025 9:00 AM IST

Researchers in the Michael E. DeBakey Department of Surgery at Baylor College of Medicine, the QIMR Berghofer Medical Research Institute in Brisbane,...

Adding GLP-1 RA to SGLT2i Reduces Mortality and Hospitalization in Heart Failure and ASCVD Patients: Study

Dr. Prem Aggarwal4 March 2025 8:00 AM IST

Taiwan: A recent cohort study has highlighted the potential benefits of combining glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with...

Mechanical Valves Offer Survival Advantage Over Bioprosthetic Valves in Younger Aortic Valve Replacement Patients: JACC

Dr. Prem Aggarwal27 Feb 2025 8:15 AM IST

USA: A recent study published in the Journal of the American College of Cardiology has provided valuable insights into the survival outcomes of...

Cigars, Pipes, and Smokeless Tobacco: More Harm to the Heart Than Expected, Study Finds

Dr. Prem Aggarwal25 Feb 2025 8:00 PM IST

USA: A new study published in JAMA Network Open sheds light on the cardiovascular risks associated with noncigarette tobacco products, such as cigars,...

Sotagliflozin significantly lowers Heart Attack and Stroke Risk, reports Lancet study

Dr. Prem Aggarwal20 Feb 2025 9:00 AM IST

Sotagliflozin, recently approved by the FDA for treating type 2 diabetes and kidney disease in patients with cardiovascular risk factors, has been...

Tricaprin can improve survival and recovery from HF in patients with triglyceride deposit cardiomyovasculopathy: Study

Dr. Prem Aggarwal18 Feb 2025 8:30 AM IST

Heart transplant is a scary and serious surgery with high cost, but for patients with heart failure it can be the only option for cure. Now, however,...

Novel Model May Predict Arrhythmic Risk in FLNCtv Carriers, Assist Decision of Prophylactic ICD Implantation: JAMA

Dr. Prem Aggarwal15 Feb 2025 9:00 AM IST

USA: A recent study by the Filamin C Registry Consortium has highlighted the significant arrhythmic risk in carriers of Filamin C truncating variants...

Salt Substitution Reduces Stroke Recurrence and Mortality: SSaSS Trial Highlights Cost-Effective Prevention Strategy

Dr. Prem Aggarwal14 Feb 2025 9:00 AM IST

China: A recent randomized clinical trial has highlighted the potential health benefits of replacing regular salt with a salt substitute in...

Tirzepatide versus Semaglutide- Surmount-5 trial reveals head-on comparison results

Dr. Prem Aggarwal5 Dec 2024 12:00 PM IST

US: Sharing the topline results from the SURMOUNT-5 phase 3b open-label randomized clinical trial, Eli Lilly and Company announced that participants...

Greater Splanchnic Nerve Ablation Shows Feasibility but No Clinical Benefit in HFpEF Patients: REBALANCE-HF Trial

Dr. Prem Aggarwal11 Oct 2024 9:00 AM IST

USA: A recent study has emerged from the REBALANCE-HF randomized clinical trial, exploring the efficacy of endovascular ablation of the greater...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok